Cadrenal Therapeutics, Inc. Common Stock (CVKD) financials · $20.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cadrenal Therapeutics, Inc. Common Stock (CVKD) $20.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$13.5M | -$11.0M |
| Net Income | -$13.2M | -$10.7M |
| EPS (Diluted) | -$6.64 | -$8.73 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4.33M | $10.1M |
| Current Assets | $4.32M | $10.1M |
| Cash & Equivalents | $4.01M | $10.0M |
| PP&E | $5.17K | $6.94K |
| Total Liabilities | $1.59M | $2.68M |
| Current Liabilities | $1.59M | $2.68M |
| Shareholders' Equity | $2.74M | $7.44M |
| Retained Earnings | -$39.0M | -$25.7M |
| Line | FY2022 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$1.20M | -$12.6M |
| CapEx | $2.28K | $5.10K |
| Investing Cash Flow | -$2.28K | -$5.10K |
| Financing Cash Flow | $1.24M | $6.60M |
| Free Cash Flow | -$1.21M | -$12.6M |
FAQ
What is CVKD P/E and revenue?
Cadrenal Therapeutics, Inc. Common Stock (CVKD) $20.2M cap.
What is CVKD revenue?
CVKD income-statement cache has no revenue figure yet.
Is CVKD profitable?
Cadrenal Therapeutics, Inc. Common Stock last cached net income is -$13.2M (FY2025).
What are CVKD total assets?
Cadrenal Therapeutics, Inc. Common Stock last cached total assets are $4.33M (FY2025).
What is CVKD free cash flow?
Cadrenal Therapeutics, Inc. Common Stock last cached free cash flow is -$1.21M (FY2022).
Not investment advice. Cached statements, not a live tape.